Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Dana-Farber, Roche, Canon, Qiagen, Win US Patents

Premium

The Dana-Farber Cancer Institute has been awarded US Patent No. 8,623,603, "Full cold-PCR enrichment with reference blocking sequence."

Gerassimos Makrigiorgos is named as the inventor.


Roche Diagnostics has been awarded US Patent No. 8,623,602, "Lysis and reverse transcription for mRNA quantification."

Michael Kubista, Linda Stroembom, and Neven Zoric are named as inventors.


Canon has been awarded US Patent No. 8,623,637, "Nucleic acid amplification apparatus and thermal cycler."

Ikumasa Ikeda is named as the inventor.


Qiagen has been awarded US Patent No. 8,624,020, "Method for isolating and purifying nucleic acids."

Ralf Himmelreich and Sabine Werner are named as inventors.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.